Paydirt
MH
Insider

Michael Thomas Henderson

Director

Michael Thomas Henderson (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $10.6M of APGE (80,000 sh × $132.54, as filed), executed Jun 22.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$36.0M
shares × price, as filed
Last traded
Jul 8
Filed Jul 10

Median ADV $371.2M across their filed names

Open performance
Volume by month
$14.1M$7.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $2.2MNov 2024 · sells $828KDec 2024 · sells $620KJan 2025 · sells $733KFeb 2025 · sells $609KMar 2025 · sells $220KNov 2025 · sells $1.3MDec 2025 · sells $4.5MJan 2026 · sells $1.6MFeb 2026 · sells $1.2MMar 2026 · sells $1.5MApr 2026 · sells $1.6MMay 2026 · sells $7.6MJun 2026 · sells $14.1MJul 2026 · sells $2.7M
Buys $0 Sells $41.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 13 filings

Sector per market data · by filing · past 12 months

Most traded names
APGE Apogee Therapeutics, Inc. APGE · 0 buys · 17 sells 17 filings SYRE Spyre Therapeutics, Inc. SYRE · 0 buys · 2 sells 2 filings
Recent filings
APGESALE Apogee Therapeutics, Inc. View filing → $620K
13,328 sh × $46.50
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET
APGESALE Apogee Therapeutics, Inc. View filing → $828K
14,000 sh × $59.17
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET
APGESALE Apogee Therapeutics, Inc. View filing → $2.2M
40,000 sh across 2 lots
Exec Oct 2 2024
Filed Oct 4 2024 · 5:30 PM ET